Treace Medical Concepts, Inc.
NASDAQ:TMCI
7.94 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 68.708 | 45.086 | 44.455 | 51.108 | 62.212 | 40.758 | 41.953 | 42.195 | 49.769 | 33.055 | 29.967 | 29.047 | 33.439 | 21.619 | 20.654 | 18.707 | 24.105 | 14.266 | 7.739 | 11.256 |
| Cost of Revenue
| 13.231 | 8.954 | 8.781 | 10.127 | 11.469 | 7.998 | 7.675 | 8.039 | 9.742 | 6.624 | 5.291 | 5.506 | 6.307 | 4.248 | 3.944 | 3.327 | 5.084 | 2.911 | 2.085 | 2.389 |
| Gross Profit
| 55.477 | 36.132 | 35.674 | 40.981 | 50.743 | 32.76 | 34.278 | 34.156 | 40.027 | 26.431 | 24.676 | 23.541 | 27.132 | 17.371 | 16.71 | 15.38 | 19.021 | 11.355 | 5.654 | 8.867 |
| Gross Profit Ratio
| 0.807 | 0.801 | 0.802 | 0.802 | 0.816 | 0.804 | 0.817 | 0.809 | 0.804 | 0.8 | 0.823 | 0.81 | 0.811 | 0.804 | 0.809 | 0.822 | 0.789 | 0.796 | 0.731 | 0.788 |
| Reseach & Development Expenses
| 5.21 | 4.963 | 5.157 | 5.259 | 4.152 | 4.35 | 3.526 | 3.412 | 3.749 | 3.799 | 2.984 | 3.052 | 3.377 | 2.537 | 2.422 | 1.868 | 1.922 | 1.511 | 0.982 | 1.433 |
| General & Administrative Expenses
| 13.612 | 13.528 | 14.218 | 14.362 | 13.449 | 12.686 | 10.031 | 10.865 | 10.406 | 8.916 | 7.015 | 6.662 | 7.027 | 4.31 | 4.329 | 2.766 | 2.039 | 1.804 | 1.401 | 1.295 |
| Selling & Marketing Expenses
| 36.859 | 32.775 | 37.681 | 40.328 | 39.924 | 33.542 | 33.773 | 33.655 | 29.369 | 25.034 | 26.61 | 21.923 | 22.325 | 15.984 | 14.01 | 12.148 | 11.425 | 8.103 | 4.789 | 7.338 |
| SG&A
| 50.471 | 46.303 | 51.899 | 54.69 | 53.373 | 46.228 | 43.804 | 44.52 | 39.775 | 33.95 | 33.625 | 28.585 | 29.352 | 20.294 | 18.339 | 14.914 | 13.464 | 9.907 | 6.19 | 8.633 |
| Other Expenses
| 0 | 0 | 0.112 | 0.074 | 0.096 | 0.023 | 0.095 | 0.128 | 0 | -0.045 | -0.003 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 55.681 | 51.266 | 57.056 | 59.949 | 57.525 | 50.578 | 47.33 | 47.932 | 43.524 | 37.749 | 36.609 | 31.637 | 32.729 | 22.831 | 20.761 | 16.782 | 15.386 | 11.418 | 7.172 | 10.066 |
| Operating Income
| -0.204 | -15.134 | -21.382 | -18.968 | -6.782 | -17.818 | -13.052 | -13.776 | -3.497 | -11.318 | -11.933 | -8.096 | -5.597 | -5.46 | -4.051 | -1.402 | 3.635 | -0.063 | -1.518 | -1.199 |
| Operating Income Ratio
| -0.003 | -0.336 | -0.481 | -0.371 | -0.109 | -0.437 | -0.311 | -0.326 | -0.07 | -0.342 | -0.398 | -0.279 | -0.167 | -0.253 | -0.196 | -0.075 | 0.151 | -0.004 | -0.196 | -0.107 |
| Total Other Income Expenses Net
| -0.297 | -0.226 | 0.176 | 0.292 | 0.501 | 0.297 | 0.781 | 0.322 | -0.915 | -0.815 | -5.301 | -0.94 | -1.022 | -0.958 | -1.032 | -1.03 | -1.068 | -2.592 | -0.455 | -0.408 |
| Income Before Tax
| -0.501 | -15.36 | -21.206 | -18.676 | -6.281 | -17.521 | -12.271 | -13.454 | -4.412 | -12.133 | -17.234 | -9.036 | -6.619 | -6.418 | -5.083 | -2.432 | 2.567 | -2.655 | -1.973 | -1.607 |
| Income Before Tax Ratio
| -0.007 | -0.341 | -0.477 | -0.365 | -0.101 | -0.43 | -0.292 | -0.319 | -0.089 | -0.367 | -0.575 | -0.311 | -0.198 | -0.297 | -0.246 | -0.13 | 0.106 | -0.186 | -0.255 | -0.143 |
| Income Tax Expense
| 0 | 0 | 0 | 1.866 | 0.509 | -1.564 | 1.377 | -0.322 | -0.917 | 0.815 | 0.943 | 0.94 | 1.028 | 0.005 | 0.006 | 0.001 | -1.746 | 0 | 0.003 | 0.033 |
| Net Income
| -0.501 | -15.36 | -21.206 | -18.676 | -6.281 | -17.521 | -12.271 | -13.132 | -3.495 | -12.948 | -17.234 | -9.976 | -6.619 | -6.418 | -5.083 | -2.432 | 2.406 | -2.655 | -1.973 | -1.607 |
| Net Income Ratio
| -0.007 | -0.341 | -0.477 | -0.365 | -0.101 | -0.43 | -0.292 | -0.311 | -0.07 | -0.392 | -0.575 | -0.343 | -0.198 | -0.297 | -0.246 | -0.13 | 0.1 | -0.186 | -0.255 | -0.143 |
| EPS
| -0.008 | -0.25 | -0.34 | -0.3 | -0.1 | -0.28 | -0.2 | -0.22 | -0.063 | -0.23 | -0.31 | -0.18 | -0.12 | -0.12 | -0.1 | -0.048 | 0.051 | -0.061 | -0.045 | -0.037 |
| EPS Diluted
| -0.008 | -0.25 | -0.34 | -0.3 | -0.1 | -0.28 | -0.2 | -0.22 | -0.063 | -0.23 | -0.31 | -0.18 | -0.12 | -0.12 | -0.1 | -0.048 | 0.051 | -0.061 | -0.045 | -0.037 |
| EBITDA
| 3.05 | -11.89 | -17.778 | -15.45 | -3.208 | -14.661 | -9.256 | -10.619 | -2.184 | -10.484 | -15.036 | -7.751 | -5.315 | -5.266 | -3.945 | -1.284 | 3.843 | 0.272 | -1.155 | -0.895 |
| EBITDA Ratio
| 0.044 | -0.264 | -0.433 | -0.334 | -0.081 | -0.437 | -0.236 | -0.267 | -0.062 | -0.317 | -0.38 | -0.267 | -0.167 | -0.244 | -0.191 | -0.069 | 0.087 | 0.019 | -0.149 | -0.077 |